stoxline Quote Chart Rank Option Currency Glossary
  
(OBIO)
  0 (0%)    02-06 12:19
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-02-06 11:52:01 AM
Short term     
Mid term     
Targets 6-month :  7.35 1-year :  8.59
Resists First :  6.3 Second :  7.35
Pivot price 5.49
Supports First :  4.86 Second :  3.98
MAs MA(5) :  5.71 MA(20) :  5.45
MA(100) :  5.35 MA(250) :  5.87
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  87.1 D(3) :  79.3
RSI RSI(14): 59.1
52-week High :  8.86 Low :  3.96
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ OBIO ] has closed below upper band by 6.0%. Bollinger Bands are 23.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.17 - 6.19 6.19 - 6.21
Low: 5.69 - 5.72 5.72 - 5.74
Close: 5.93 - 5.98 5.98 - 6.02
Company Description

Headline News

Wed, 05 Feb 2025
Obio/Akpor chapter, a new ICAN district, to promote professional development, members health - Businessday

Wed, 05 Feb 2025
Medtronic M&A Veteran Who Led $60B+ in Deals Joins Orchestra BioMed Board - StockTitan

Thu, 02 Jan 2025
Orchestra Orchestra BioMed stock rated Overweight on novel medtech model - Investing.com

Wed, 18 Dec 2024
Here's Why We're Watching Orchestra BioMed Holdings' (NASDAQ:OBIO) Cash Burn Situation - Simply Wall St

Tue, 03 Dec 2024
OBIO® Celebrates 15th Anniversary With Fresh New Look - Business Wire

Tue, 12 Nov 2024
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 38 (M)
Held by Insiders 1.758e+007 (%)
Held by Institutions 22 (%)
Shares Short 703 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -5.981e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 655.7 %
Return on Equity (ttm) -39.3 %
Qtrly Rev. Growth 2.65e+006 %
Gross Profit (p.s.) 330.73
Sales Per Share -223.57
EBITDA (p.s.) 5.97561e+006
Qtrly Earnings Growth -1.7 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -48 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.03
Price to Cash Flow 1.99
Stock Dividends
Dividend 0
Forward Dividend 736730
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android